Filing Details

Accession Number:
0001682873-19-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-03 13:09:04
Reporting Period:
2018-12-21
Accepted Time:
2019-01-03 13:09:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1018735 Nymox Pharmaceutical Corp NYMX In Vitro & In Vivo Diagnostic Substances (2835) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1682873 Erik Danielsen 9900 Cavendish Blvd
St Laurent A8 H4M 2V2
Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-12-21 6,000 $1.35 20,900 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct